OncoRNA

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-07-2025	1 d early	2025-00331862
31-12-2023	31-07-2024	04-10-2024	65 d late	2024-00499973

Metric	This company	Sector median	Position in the sector
Solvency	-98.1%	55.0%	better than 10% of 174 sector peers
Net result	€-38k	€16k	better than 15% of 174 sector peers
Equity	€-16k	€70k	better than 11% of 174 sector peers
Gross operating margin	€-36k	€41k	better than 10% of 175 sector peers
Staff costs	€1k	€58k	higher than 17% of 38 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€17k
Current assets	29/58	€17k
Amounts receivable within one year	40/41	€2k
Cash & bank	54/58	€15k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€17k
Equity	10/15	€-16k
Contributions / capital	10/11	€62k
Accumulated profits (losses)	14	€-78k
Amounts payable	17/49	€33k
Amounts payable within one year	42/48	€33k
Trade debts payable within one year	44	€6k
Income statement
Gross operating margin	9900	€-36k
Operating result	9901	€-38k
Financial charges	65	€454
Result before taxes	9903	€-38k
Net result for the period	9904	€-38k
Result to be appropriated	9905	€-38k

Summary